Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
73 hedge funds and large institutions have $285M invested in Tetraphase Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 9 closing their positions.
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
54% more capital invested
Capital invested by funds: $185M → $285M (+$99.9M)
29% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 17
14% more funds holding
Funds holding: 64 → 73 (+9)
6% less call options, than puts
Call options by funds: $2.16M | Put options by funds: $2.29M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.76M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$5.96M |
| 3 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
+$5.11M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.13M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$3.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$15.5M |
| 2 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$10.9M |
| 3 |
PC
PointState Capital
New York
|
-$5.36M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.62M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.84M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DCC
76
Dow Chemical Company
Midland,
Michigan
| – | -$333K | -1,235 | Closed |
|
|
CI
77
Cowen Inc
New York
| – | -$248K | -920 | Closed |
|
78
Group One Trading
Chicago,
Illinois
| – | -$149K | -555 | Closed |
|
79
ProShare Advisors
Bethesda,
Maryland
| – | -$145K | -537 | Closed |
|
|
BJ
80
BlackRock Japan
Tokyo,
Japan
| – | -$99K | -368 | Closed |
|
|
VFA
81
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$25K | -94 | Closed |
|
82
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$5K | -18 | Closed |
|
TTPH Hedge Fund Activity: Q3 2014 in Review
73 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q3 2014, worth a combined $285M — up 54% from $185M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TTPH positions and 9 closed out — a net gain of 9 holders — while 22 added to existing stakes and 17 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $6.76M. The largest seller was Broadfin Capital, cutting an estimated $15.5M.
- 73 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q3 2014, up from 64 in Q2 2014.
- Funds reported $285M of Tetraphase Pharmaceuticals, Inc. stock for Q3 2014, up 54% quarter-over-quarter.
- 18 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q3 2014 and 9 closed out, a net change of +9 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q3 2014 was Adage Capital Partners, an estimated $6.76M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $15.5M sold.
Based on aggregated 13F filings for Q3 2014.